NOX enzymes as novel targets for drug development
Open accessThe DOI matches its Crossref record; 308 of the 308 references it cites were found in a registry or an index.
Abstract
The members of the NOX/DUOX family of NADPH oxidases mediate such physiologic functions as host defense, cell signaling, and thyroid hormone biosynthesis through the generation of reactive oxygen species (ROS), including superoxide anion and hydrogen peroxide. Moreover, ROS are involved in a broad range of fundamental biochemical and cellular processes, and data accumulated in recent years indicate that the NOX enzymes comprise one of the most important biological sources of ROS. Given the high biochemical reactivity of ROS, it is not surprising that they have been implicated in a wide variety of pathologies and diseases. Prominent among the settings that feature ROS-mediated tissue injury are disorders associated with inflammation, aging, and progressive degenerative changes in cells and organ systems, and it appears that essentially no organ system is exempt. Among the disorders currently believed to be mediated at least in part by NOX-derived ROS are hypertension, aortic aneurysm, myocardial infarction (and other ischemia-reperfusion disorders), pulmonary fibrosis and hypertension, amyotropic lateral sclerosis, Alzheimer's disease, Parkinson's disease, ischemic stroke, diabetic nephropathy, and renal cell carcinoma. Several small-molecule and peptide inhibitors of the NOX enzymes have been useful in experimental studies, but issues of specificity, potency, and toxicity militate against any of the existing published compounds as candidates for drug development. Given the br…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This includes Nox enzymes but also, for example, complex I of the ETC [63,250,251], iNOS [400,401] and XO [394,399] as well as calcium transporters [402].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [250]
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Self-citationIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Tissue Destruction by Neutrophils
(1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210513 · Cited by 3,631
NOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125
Self-citationMitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Cited by
Items 101–200 of 212
Liwa, A. C., Barton, E. N., Cole, W. C., & Nwokocha, C. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802104-0.00015-9 · Cited by 60
A subset of N-substituted phenothiazines inhibits NADPH oxidases
Seredenina, T., Chiriano, G., Filippova, A., Nayernia, Z., Mahiout, Z., Fioraso-Cartier, L., Plastre, O., Scapozza, L., Krause, K.-H., & Jaquet, V. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.023 · Cited by 45
Self-citationThe 1027th target candidate in stroke: Will NADPH oxidase hold up?
Radermacher, K. A., Wingler, K., Kleikers, P. W. M., Altenhöfer, S., Hermans, J. J. R., Kleinschnitz, C., & Schmidt, H. H. H. W. (2012) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-4-11 · Cited by 45
“[47,48].”
Erlich, J. R., To, E. E., Liong, S., Brooks, R. D., Vlahos, R., O’Leary, J. J., Brooks, D. A., & Selemidis, S. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8028 · Cited by 49
“These inhibitors have been reviewed (12, 18, 32, 47, 64, 82, 149, 151, 175) in the context of chronic diseases such as CVD, cancer, and neuronal diseases.”
BackgroundBallot, C., Martoriati, A., Jendoubi, M., Buche, S., Formstecher, P., Mortier, L., Kluza, J., & Marchetti, P. (2014) · Marine Drugs · doi:10.3390/md12020779 · Cited by 42
“There are growing evidences that enzymes of the NOX family play an important role in the redox signaling in healthy and tumor cells [29].”
BackgroundA diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells
Dentelli, P., Barale, C., Togliatto, G., Trombetta, A., Olgasi, C., Gili, M., Riganti, C., Toppino, M., & Brizzi, M. F. (2012) · Diabetologia · doi:10.1007/s00125-012-2734-7 · Cited by 43
“NADPH oxidase (NOX)-mediated reactive oxygen species (ROS) production [24] has been reported to be involved in the control of stem and progenitor cell fate [25], as well as in neural cell reprogramming [26].”
BackgroundNADPH oxidase (NOX2) activity is a modifier of survival in ALS
Marrali, G., Casale, F., Salamone, P., Fuda, G., Caorsi, C., Amoroso, A., Brunetti, M., Restagno, G., Barberis, M., Bertuzzo, D., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7470-0 · Cited by 44
Fenyo, I. M., Albulescu, I. C., Raicu, M., & Manea, A. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.03.006 · Cited by 42
Murphy‐Marshman, H., Quensel, K., Shiwen, X., Barnfield, R., Kelly, J., Peidl, A., Stratton, R. J., & Leask, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186740 · Cited by 42
Cytosolic PCNA interacts with p47phox and controls NADPH oxidase NOX2 activation in neutrophils
Ohayon, D., Chiara, A. D., Dang, P. M., Thiéblemont, N., Chatfield, S., Marzaioli, V., Burgener, S. S., Mocek, J., Candalh, C., Pintard, C., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20180371 · Cited by 45
“ROS are involved in numerous inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, atherosclerosis, and aging (Lambeth et al., 2008).”
BackgroundNox enzymes and oxidative stress in atherosclerosis
Simionescu, M. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s291 · Cited by 44
Control of singlet oxygen production in experiments performed on single mammalian cells
Westberg, M., Bregnhøj, M., Blázquez‐Castro, A., Breitenbach, T., Etzerodt, M., & Ogilby, P. R. (2016) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2016.01.028 · Cited by 40
NADPH Oxidases: Molecular Understanding Finally Reaching the Clinical Level?
Guzik, T. J., & Griendling, K. K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2615 · Cited by 40
“At the same time, we are still very limited in the development of new treatments for diverse NADPH oxidase–associated diseases (29).”
Zheng, M., Liu, K., Li, L., Feng, C., & Wu, G. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02251-0 · Cited by 41
“There is substantial evidence that NOX enzymes are present in various models of induced fibrosis, and NOX4 plays a critical role in the development of pulmonary fibrosis [33–35].”
BackgroundLiu, F., Havens, J. F., Yu, Q., Wang, G., Davisson, R. L., Pickel, V. M., & Iadecola, C. (2012) · Europe PMC (PubMed Central) · Cited by 45
Dahan, I. M., & Pick, E. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1007-4 · Cited by 36
Chen, J., Hsieh, M., Lin, C., Lin, C.-C., Hsi, Y., Lo, Y., Chuang, Y., Hsieh, M.-J., & Chen, M. (2017) · Oncotarget · doi:10.18632/oncotarget.22444 · Cited by 36
“NOX is a family of enzymes involved in ROS generation, which exhibits a close correlation with progression and cell death in a wide range of cancers [28, 29].”
BackgroundGarrido‐Urbani, S., Jemelin, S., Deffert, C., Carnésecchi, S., Basset, O., Szyndralewiez, C., Heitz, F., Page, P., Montet, X., Michalik, L., et al. (2011) · PLoS ONE · doi:10.1371/annotation/a392bbef-b0ec-4c70-b403-74a7bad85178 · Cited by 36
Self-citationYun, S. P., Lee, S., Oh, S. Y., Jung, Y. H., Ryu, J. M., Suh, H. N., Kim, M., Oh, K. B., & Han, H. J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12681 · Cited by 37
“Reactive oxygen species (ROS), essential regulators of cell metabolism, are also known to be toxic radicals that can damage macromolecules (Cuzzocrea et al., 2001; Lambeth et al., 2008).”
BackgroundSpencer, N. Y., Yang, Z., Sullivan, J. C., Klein, T., & Stanton, R. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200249 · Cited by 35
Pharmacological Potential of NOX2 Agonists in Inflammatory Conditions
Hultqvist, M. H., Olofsson, P., Wallner, F. K., & Holmdahl, R. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5788 · Cited by 34
“Most attempts to therapeutically modulate the effect of NOX enzymes are directed to the identification of compounds that inhibit ROS production (55, 67).”
Land, W. G. (2011) · Transplantation Reviews · doi:10.1016/j.trre.2011.07.001 · Cited by 31
“As reviewed [52], the compound has been used widely in both cellular and in vivo studies as evidence for the involvement of an NOX in various physiological and pathological conditions.”
BackgroundCell-Free NADPH Oxidase Activation Assays: “In Vitro Veritas”
Pick, E. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-845-4_22 · Cited by 31
“With the increasing interest in the development of Nox inhibitors [ 84 , 85 ], cell-free assays are key components in the search for such compounds (predominantly in the form of highthroughput screening).”
BackgroundPharmacological approaches to coronary microvascular dysfunction
Guarini, G., Huqi, A., Morrone, D., Capozza, P., Todiere, G., & Marzilli, M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.008 · Cited by 35
Hultqvist, M. H., Sareila, O., Vilhardt, F., Norin, U., Olsson, L. M., Olofsson, P., Hellman, U., & Holmdahl, R. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3440 · Cited by 30
“The finding that low ROS production-mediated arthritis (49) was surprising, as it required a mechanism in which ROS, produced by the NOX2 complex, protected against, rather than exaggerated inflammation, as the general dogma proposes [for an overview see (37, 41)].”
Recent Developments in the Probes and Assays for Measurement of the Activity of NADPH Oxidases
Zielonka, J., Hardy, M., Michalski, R., Sikora, A., Zielonka, M., Cheng, G., Ouari, O., Podsiadły, R., & Kalyanaraman, B. (2017) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-017-0813-6 · Cited by 31
Domínguez‐Luis, M. J., Armas‐González, E., Herrera-García, A., Arce-Franco, M. T., Feria, M., Vicente‐Manzanares, M., Martínez-Ruiz, A., Sánchez‐Madrid, F., & Díaz‐González, F. (2018) · European Journal of Immunology · doi:10.1002/eji.201847710 · Cited by 32
Huang, X., Xiaokaiti, Y., Yang, J., Pan, J., Li, Z., Luria, V., Li, Y., Song, G., Zhu, X., Zhang, H., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.039 · Cited by 28
“These six subunits translocate to the membrane to trigger complex assembly upon gp91phox activation, leading to generation of superoxide (Lambeth et al., 2008).”
Cell-Free NADPH Oxidase Activation Assays: A Triumph of Reductionism
Pick, E. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0154-9_23 · Cited by 29
Oxidative Stress and Neonatal Respiratory Extracorporeal Membrane Oxygenation
Raffaeli, G., Ghirardello, S., Passera, S., Mosca, F., & Cavallaro, G. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01739 · Cited by 30
NADPH Oxidases and Their Roles in Skin Homeostasis and Carcinogenesis
Rudolf, J., Raad, H., Taïeb, A., & Rezvani, H. R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7282 · Cited by 29
“The NADPH oxidases have received considerable interest in the last two decades, especially in connection with many metabolic diseases, aging, and carcinogenesis (77, 100).”
Sp3 transcription factor is crucial for transcriptional activation of the human NOX4 gene
Katsuyama, M., Hirai, H., Iwata, K., Ibi, M., Matsuno, K., Matsumoto, M., & Yabe‐Nishimura, C. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08018.x · Cited by 27
Golmohammadi, M., Ivraghi, M. S., Hasan, E. K., Huldani, H., Zamanian, M. Y., Rouzbahani, S., Mustafa, Y. F., Al-Hasnawi, S. S., Alazbjee, A. A. A., Khalajimoqim, F., et al. (2024) · Clinical and Experimental Nephrology · doi:10.1007/s10157-024-02525-3 · Cited by 24
Towards specific NADPH oxidase inhibition by small synthetic peptides
Benna, J. E., Dang, P. M., & Périanin, A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1008-3 · Cited by 28
“Many other small molecules have been shown to inhibit the phagocyte NADPH oxidase and other NOXs [33–36], but there are currently no specific chemical inhibitors of the phagocyte NADPH oxidase.”
BackgroundTian, Z., Zhang, H., Dixon, J., Traphagen, N. A., Wyatt, T. A., Kharbanda, K. K., Chadwick, S. S., Kolliputi, N., & Allen‐Gipson, D. (2017) · Scientific Reports · doi:10.1038/srep44405 · Cited by 24
Ischemia–Reperfusion Injury: Molecular Mechanisms of Pathogenesis and Methods of Their Correction
Goncharov, R. G., & Sharapov, M. G. (2023) · Molecular Biology · doi:10.1134/s0026893323060067 · Cited by 27
Pontiki, E. A., Hadjipavlou‐Litina, D., Patsilinakos, A., Tran, T. X. M., & Marson, C. M. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.104 · Cited by 24
Cross-Linking Furan-Modified Kisspeptin-10 to the KISS Receptor
Vannecke, W., Ampè, C., Troys, M. V., Beltramo, M., & Madder, A. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00396 · Cited by 24
Rosc-Schlüter, B. I., Häuselmann, S. P., Lorenz, V., Mochizuki, M., Facciotti, F., Pfister, O., & Kuster, G. M. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr348 · Cited by 26
“Apocynin is, besides known to inhibit the regulatory NOX subunit p47 in leukocytes, implicated as an antioxidant in endothelial and smooth muscle cells,(42) and DPI inhibits flavoenzymes, including NOX.(43) Both compounds markedly decreased DCF fluorescence intensity when administered prior to a-CD29 (Figure 1C–E).”
BackgroundInfluentialKrause, K., Lambeth, D. J., & Krönke, M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1006-5 · Cited by 23
“When successful, the outcome is a drug or other therapeutic method [1, 2].”
BackgroundSelf-citationConsensus in silico computational modelling of the p22phox subunit of the NADPH oxidase
Meijles, D. N., Howlin, B. J., & Li, J.-M. (2012) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2012.05.001 · Cited by 22
Gustafson, S. J., Dunlap, K. L., McGill, C. M., & Kuhn, T. B. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/768101 · Cited by 30
“Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2012, Article ID 768101, 12 pages doi:10.1155/2012/768101 Research Article”
BackgroundInfluentialGalli, F., Bartolini, D., & Ronco, C. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14229 · Cited by 24
Chang, T., Weaver, J. R., Bowman, A. N., Leone, K. A., Raab, R., Vinik, A. I., Pittenger, G. L., & Taylor, D. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.026 · Cited by 23
Trac, D. Q., Liu, B., Pao, A. C., Thomas, S. V., Park, M., Downs, C. A., Ma, H., & Helms, M. N. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00098.2013 · Cited by 22
Traumatic brain injury, diabetic neuropathy and altered-psychiatric health: The fateful triangle
Abou‐El‐Hassan, H., Dia, B., Choucair, K., Eid, S., Najdi, F., Baki, L., Talih, F. R., Eid, A. A., & Kobeissy, F. H. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.08.008 · Cited by 59
The Role of Oxidative Stress-Induced Senescence in the Pathogenesis of Preeclampsia
Barbouti, A., Varvarousis, D., & Kanavaros, P. (2025) · Antioxidants · doi:10.3390/antiox14050529 · Cited by 22
“In addition to XO, the NOX family of enzymes have been proposed to mediate ischemia and reperfusion injury across various tissues [92–94].”
Kuhn, T. B. (2014) · BioMed Research International · doi:10.1155/2014/191767 · Cited by 23
“Strategies to block NOX activities could thus proof beneficial to blunt inflammatory stress in the diseased and aging CNS and to halt cognitive decline [66, 67].”
BackgroundAndreani, A., Granaiola, M., Locatelli, A., Morigi, R., Rambaldi, M., Varoli, L., Sega, F. V. D., Prata, C., Nguyen, T. L., Bai, R., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.033 · Cited by 18
“Synthesis of 3-(3,4,5-trimethoxybenzylidene)- and 3-[(3,4 NAD(P)H oxidase enzymes (Nox) constitute a family of structural homologs of phagocytic Nox (Nox2 or gp91phox) and are one of the major sources of reactive oxygen species (ROS) in many cell types [6,7].”
Characterisation of Nox4 Inhibitors from Edible Plants
Kofler, P., Pircher, H., von Grafenstein, S., Diener, T., Höll, M., Liedl, K. R., Siems, K., & Jansen‐Dürr, P. (2013) · Planta Medica · doi:10.1055/s-0032-1328129 · Cited by 18
“Given the pleiotropic effects of Nox4 on a variety of physiological and pathophysiological processes, isotype-specific inhibitors of Nox4 would be potentially very useful [2,3,24,25].”
Backgroundde Oliveira, J. K., Ronik, D. F. V., Ascari, J., Mainardes, R. M., & Khalil, N. M. (2016) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2016.08.001 · Cited by 17
“The inhibition of NADPH oxidase represents a therapeutic target to prevent various diseases such as cancer [7–9], atherosclerosis [10], vascular and neurodegenerative diseases [11,12].”
Marrali, G., Salamone, P., Casale, F., Fuda, G., Cugnasco, P., Caorsi, C., Amoroso, A., Calvo, A., Lopiano, L., Cocito, D., et al. (2016) · European Journal of Neurology · doi:10.1111/ene.12971 · Cited by 18
“NOX enzymes are increasingly recognized as key regulators of pathological situations where oxidative stress is involved and leads to tissue oxidative damage [8,9].”
BackgroundLiu, Y., Gu, H., Huang, T., Wei, X., Ma, W., Liu, D., He, Y., Luo, W., Huang, J., Zhao, D., et al. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13383 · Cited by 19
Neurovascular unit in ischemic stroke in older adults: a narrative review
Wang, C., Yang, Y., Xiong, T., & Li, S. (2025) · Aging advances. · doi:10.4103/agingadv.agingadv-d-24-00031 · Cited by 16
Challenges, Progresses, and Promises for Developing Future NADPH Oxidase Therapeutics
Bedard, K., Whitehouse, S., & Jaquet, V. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6450 · Cited by 16
“However, it has been proposed that NOX enzymes might be among the long-sought sources of pathological oxidative damage (5).”
BackgroundHan, D., Wang, F., & Shen, D. (2024) · Theranostics · doi:10.7150/thno.99961 · Cited by 16
“Upon activation by ischemic stress, inflammatory cytokines, or mechanical strain, NOX enzymes catalyze the transfer of electrons from NADPH to molecular oxygen, producing superoxide [29].”
BackgroundChan, Y.-P., Chuang, C., Lee, I., & Yang, N.-C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.886988 · Cited by 18
“NOXs make up the only known enzyme family with the sole function of producing ROS (30, 31).”
BackgroundInfluentialPing, M., Xiao, W. L., Mo, L., Xiao, X., Song, S., Tang, W., & Yang, X. (2014) · Pharmacology · doi:10.1159/000363577 · Cited by 15
Methods for Detection of NOX-Derived Superoxide Radical Anion and Hydrogen Peroxide in Cells
Augsburger, F., Филиппова, А., & Jaquet, V. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9424-3_13 · Cited by 14
Optimization and Characterization of an Inhibitor for NADPH Oxidase 1 (NOX-1)
Gianni, D., Nicolas, N., Zhang, H., Mardirossian, C. D., Kister, J., Martínez, L. E., Ferguson, J., Roush, W. R., Brown, S., Bokoch, G., et al. (2011) · Europe PMC (PubMed Central) · Cited by 14
Mizrachi, A., Ben‐Aharon, I., Li, H., Bar‐Joseph, H., Bodden, C., Hikri, E., Popovtzer, A., Shalgi, R., & Haimovitz‐Friedman, A. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.109969 · Cited by 12
New Developments in the Therapy of Pulmonary Fibrosis
Scriabine, A., & Rabin, D. U. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57011-6 · Cited by 14
Targeting the myofibroblast to improve wound healing
Hinz, B. (2016) · Elsevier eBooks · doi:10.1016/b978-1-78242-455-0.00003-3 · Cited by 13
Karmacharya, U., Regmi, S. C., Awasthi, B. P., Chaudhary, P., Kim, Y. E., Lee, I., Nam, T., Kim, J., & Jeong, B. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128059 · Cited by 10
Mogensen, D. J., Etzerodt, M., & Ogilby, P. R. (2022) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2022.113894 · Cited by 11
Oxidative, Nitrosative, and Chlorinative Stress: Biomarkers
Bartosz, G., & Sadowska‐Bartosz, I. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_1 · Cited by 13
Santos, G. B., Ribeiro, A. C. G., Lima, S. N. P., Trostchansky, A., Cerdeira, C. D., & Brigagão, M. R. P. L. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.11.016 · Cited by 10
Graves’ disease and the risk of Parkinson’s disease: a Korean population-based study
Cho, Y. Y., Kim, B., Shin, D. W., Youn, J., Mok, J., Kim, C., Kim, S. W., Chung, J. H., Han, K., & Kim, T. H. (2022) · Brain Communications · doi:10.1093/braincomms/fcac014 · Cited by 11
“In addition, there is evidence regarding common abnormalities that increase susceptibility to both Parkinson’s disease and thyroid disease, which may involve RASD2,(7) WSB1,(8) MAPT(10) and NOX/DUOX.(9) Two European cohort studies have provided epidemiological evidence that Graves’ disease may be associated”
Yang, X., Yang, Y., Liu, K., & Zhang, C. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14916 · Cited by 11
“ROS can directly participate in the regulation of cell differentiation, proliferation, and apoptosis as a second messenger [67].”
BackgroundLiu, Y., Liang, S., Shi, D., Zhang, Y., Bai, C., & Ye, R. D. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285206 · Cited by 11
Ischemia-Reperfusion Injury: Molecular Mechanisms of Pathogenesis and Methods of Their Correction
Goncharov, R. G., & Sharapov, M. G. (2023) · Molecular Biology · doi:10.31857/s0026898423060071 · Cited by 21
Tùng, N. H., Sun, K., Fan, J., Shoyama, Y., & Han, J. (2014) · Microcirculation · doi:10.1111/micc.12147 · Cited by 8
“Emerging evidence suggests the involvement of NADPH oxidase in I/R injury of various organs [11,15].”
BackgroundPlumel, M. I., Benhaim-Delarbre, M., Rompais, M., Thiersé, D., Sorci, G., DORSSELAER, A. V., Criscuolo, F., & Bertile, F. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.09.008 · Cited by 8
“For instance, innate immunity relies on production of nitric oxide and superoxide by macrophages [27, 28] which may have nonspecific deleterious impact on host cells [29].”
The cell origin of reactive oxygen species and its implication for evolutionary trade-offs
Kervella, M., Bertile, F., Bouillaud, F., & Criscuolo, F. (2025) · Open Biology · doi:10.1098/rsob.240312 · Cited by 10
“This systemic expression gives them the ability to regulate many physiological processes, either via direct damages induced by the ROS they produce (e.g. immunity [113] or indirectly via the impact of ROS on cell signalling [51]; see below).”
Cell Death and Stress Signaling in Glycogen Storage Disease Type I
Kim, S. Y., & Bae, Y. S. (2009) · Molecules and Cells · doi:10.1007/s10059-009-0126-8 · Cited by 8
Nandi, A., & Bishayi, B. (2015) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.09.007 · Cited by 6
Reid, M., Spence, J. R., Nwokocha, M., Palacios, J. C., & Nwokocha, C. R. (2018) · Studies in natural products chemistry · doi:10.1016/b978-0-444-64056-7.00002-7 · Cited by 7
Antioxidants Versus Reactive Oxygen Species – A Tug of War for Human Benefits?
Ndhlala, A. R., Ncube, B., & van Staden, J. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_181 · Cited by 6
Patents and applications of N-sulfonated N-heterocycles
Elgemeie, G. H., Azzam, R. A., Zaghary, W. A., Aly, A. A., Metwally, N. H., Sarhan, M. O., Abdelhafez, E. M. N., & Elsayed, R. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822179-2.00004-5 · Cited by 4
Therapeutic correlation of NOX4 and diabetes-mediated neurodegeneration
Tiwari, C., Khan, H., Grewal, A. K., & Singh, T. G. (2023) · Obesity Medicine · doi:10.1016/j.obmed.2023.100515 · Cited by 4
Ayurvedic medicine and NADPH oxidase: a possible approach to the prevention of ESRD in hyperoxaluria
Gambaro, G., Ferraro, M., & D’Addessi, A. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr182 · Cited by 4
“Since NADPH oxidases are proving to be major sources of ROS in many tissues and many pathological settings, the ideal target for preventing renal damage in severe hyperoxaluria would be the NOX (and preferably NOX 4) enzymes in the renal tubular cells [22].”
BackgroundADAMTS13--more than just TMA and TTP
Amann, K. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr158 · Cited by 4
Impaired systemic proteostasis and peripheral immune cell dysfunction in kidney diseases
Bartolini, D., Migni, A., Roberta, R., & Galli, F. (2024) · Journal of Translational Critical Care Medicine · doi:10.1097/jtccm-d-23-00016 · Cited by 3
Ermawati, T., Meilawaty, Z., & Harmono, H. (2019) · Majalah Kedokteran Gigi Indonesia · doi:10.22146/majkedgiind.28352 · Cited by 5
de Haan, J. B., Jandeleit-Dahm, K. A. M., & Allen, T. J. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-956-7_1 · Cited by 2
Antioxidant Potential of African Medicinal Plants
Ndhlala, A. R., Ncube, B., Abdelgadir, H. A., Plooy, C. P. D., & Staden, J. V. (2017) · Springer eBooks · doi:10.1007/978-3-319-67625-8_3 · Cited by 2
Oxidative Stress in Cardiac Remodeling Post-Ischemia/Reperfusion: Friend or Foe?
Abidi, E., Kaplan, A., Booz, G. W., & Zouein, F. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_12 · Cited by 2
Fridovich, I. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0001376.pub3 · Cited by 2
Phosphorylation of Ser-525 in βPix impairs Nox1-activating ability in Caco-2 cells
Kaito, Y., Kataoka, R., Mihara, T., Takechi, K., Takahira, A., Watanabe, S., Han, F., & TAMURA, M. N. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.12.010 · Cited by 1
Malan‐Müller, S. (2014) · SUNScholar (Stellenbosch University) · Cited by 1
Characterization of the ROS production in ischemia/reperfusion-induced lung injury
Sydykov, A. S., & Justus Liebig University Giessen (2009) · University writing server of the Justus Liebig University Giessen (Justus-Liebig-Universität Gießen) · doi:10.22029/jlupub-15539 · Cited by 2
Nawimanage, R. R. (2015) · Louisiana State University · doi:10.31390/gradschool_dissertations.3843 · Cited by 1
BIOMARKERS OF OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES
Sultana, R., Cenini, G., & Butterfield, D. A. (2025) · Wiley eBooks · doi:10.1002/9781119790419.ch18 · Cited by 1
Defining the Role of GGTase-I in the Development of Rheumatoid Arthritis and Atherosclerosis
Khan, O. M. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Coriat, R. (2012) · theses.fr (ABES) · doi:10.70675/3c35ac86z7dbaz4ce0z8bafz1ec9be4fc738
“La NOX2 est un complexe enzymatique multi protéique qui lorsqu’il est activé est composé de six éléments [44, 53, 60]: - Deux éléments transmembranaires qui forment le flavocytochrome b558 et constituent le noyau catalytique de l'enzyme : " gp91 ou sous-unité alpha avec une partie C-terminale cytoplasmique.”
BackgroundKeywords NADPH oxidases (NOX) Peptide inhibitors Reactive oxygen species (ROS) NOX and disease
Lambeth, K.-H. K., & Krönke, M. (2012)
SKIN REDOX BALANCE MAINTENANCE: THE NEED FOR AN NRF2- ACTIVATORS DELIVERY SYSTEM
Greenwald, M. B., Sasson, S. B., Peled, H., & Kohen, R. (2016) · doi:10.18143/jisanh_v3i3_1457
NADPH oxidases in GtoPdb v.2021.3
van der Vliet, A. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f993/2021.3
Neish, A. S. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.715348000.790952800
Metadata
- Authors
- Lambeth, J. D., Krause, K.-H., & Clark, R. A.
- Affiliations
- Emory University (US)
- University of Geneva (CH)
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Lambeth, J. David
- ORCID
- Clark, Robert A.
- Venue
- Seminars in Immunopathology
- Published
- 2008-05-29
- Volume
- 30
- Issue
- 3
- Pages
- 339-363
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- OpenAlex
- W2031193867
- Cited by
- 212
- References
- 307
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 4 · 2021: 7 · 2020: 3 · 2019: 5 · 2018: 7 · 2017: 14 · 2016: 11 · 2015: 11 · 2014: 21 · 2013: 16 · 2012: 28
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Seminars in Immunopathology (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Cancer Institute (CA084138, R01CA084138, CA 105116)
- National Institute of Allergy and Infectious Diseases (R01AI020866)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- NADPH oxidase, reactive oxygen species, superoxide, hydrogen peroxide, NOX inhibitors, drug development, isoform specificity, oxidative stress, inflammation, aging, hypertension, ischemia-reperfusion injury, neurodegenerative diseases, pulmonary fibrosis, diabetic nephropathy, renal cell carcinoma, host defense, thyroid hormone synthesis
- MeSH terms
- Animals, Drug Evaluation, Enzyme Inhibitors, Humans, Reactive Oxygen Species, NADPH Oxidases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.